Conquering Diseases

Study Of An Investigational Drug Combination For Acute Myeloid Leukemia


Seeking men and women aged 18-74 with newly diagnosed Acute Myeloid Leukemia (AML) for a study of an investigational drug combination.


Participants in this study will take two drugs pills. There are 10 study visits over 20 months and participants are asked to keep a diary of when they take their drugs, eat meals, and symptoms they may experience.

What we're hoping for

We are studying whether an investigational drug combination is safe and effective for people newly diagnosed with Acute Myeloid Leukemia (AML)

Additional Information Identifier: NCT04657081

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655